Fondaparinux Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Fondaparinux Sodium Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status To Be Discontinued. The shortage was first posted on 09/29/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 0781-3465-95
- Dosage Form
- Injection
- Presentation
- Fondaparinux Sodium, Injection, 7.5 mg/.6 mL (NDC 0781-3465-95)
- Initial Posting
- 09/29/2025
- Revised Date